CD4 and colitis: Weekly injections of anti-CD4 mAb (clone GK1.5) or isotype control mAb began at 4 wk of age, prior to colitis development (typically 10–12 wk), and lasted until 20 wk of age where colitis is typically overt in P440S mice.